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Abstract
CRISPR assisted homology directed repair enables the introduction of virtually any modification to the Saccharomyces
cerevisiae genome. Of obvious interest is the marker-free and seamless introduction of point mutations. To fulfill this
promise, a strategy that effects single nucleotide changes while preventing repeated recognition and cutting by the
gRNA/Cas9 complex is needed. We demonstrate a two-step method to introduce point mutations at 17 positions in the
S. cerevisiae genome. We show the general applicability of the method, enabling the seamless introduction of single
nucleotide changes at any location, including essential genes and non-coding regions. We also show a quantifiable
phenotype for a point mutation introduced in gene GSH1. The ease and wide applicability of this general method,
combined with the demonstration of its feasibility will enable genome editing at an unprecedented level of detail in
yeast and other organisms.
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Letter to the editor
Following the first reported application of CRISPR-Cas9
in Saccharomyces cerevisiae [1], several methods exploit-
ing the potential of this technology for yeast genome
editing were published enabling gene disruption [1–4],
gene deletion [5, 6], heterologous sequence integration
[2, 4, 5, 7, 8], and insertion of point mutations [1, 5–7].
The genome of a strain of Saccharomyces cerevisiae
evolved by genome shuffling for resistance to a toxic
lignocellulosic hydrolysate (designated R57) was recently
sequenced uncovering 17 single nucleotide variations
with its parent strain [9]. We reasoned that recent devel-
opments in CRISPR-Cas9 technology should permit the
seamless introduction of the point mutations discovered
in R57 back into the wildtype parental background for
testing phenotype to genotype associations. Similarly, we
set to revert each of these point mutations to wildtype in
the mutant strain R57. However, strategies reported for
the introduction of a point mutation using CRISPR-Cas9
suffer several caveats that restrict the range of mutations
that can be introduced at any given locus. One difficulty
is that sequencing is required to detect the successful
integration of a point mutation. However, the main chal-
lenge to using CRISPR-Cas9 for the introduction of
point mutations is the risk of repeated cutting by Cas9
after homology directed repair (HDR) of the initial double
stranded break (DSB). Indeed, point mutations may not
be located within the protospacer sequence, leaving it
intact after HDR. Even if the mutation is located close
enough to a protospacer adjacent motif (PAM) to modify
the gRNA target sequence, a single substitution is gen-
erally insufficient to prevent recognition by the gRNA/
Cas9 complex [10]. Several strategies have therefore
been devised to prevent Cas9 from cutting repeatedly
at the site of interest. Mutation of the PAM along with
the target point mutation position abolishes target rec-
ognition by the gRNA/Cas9 complex, and has allowed
the successful introduction of premature stop codons
[1, 6]. This strategy remains confined to cases where
the PAM site mutation is either silent or deemed in-
consequential. An alternative is the insertion of so-
called heterology blocks in addition to the mutation of
interest [7]. A heterology block consists in a number of
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additional silent mutations meant to abolish gRNA rec-
ognition. While heterology blocks change codon usage
in an open reading frame (ORF) and may potentially
affect mRNA translation, they represent a quick and
convenient means of introducing point mutations.
Moreover, their successful integration is easily detected
by PCR. However, the concept of a silent mutation is
meaningless in untranslated regions of the genome,
such as non-coding RNAs and intergenic sequences.
Mans et al. [5] demonstrated successful insertion of a
point mutation without altering the PAM or resorting to
a heterology block. The inserted mutation eliminated a
restriction site and replaced it with another, providing
for easy detection of successful mutants. Sequencing re-
vealed that several restriction positive clones displayed
additional unwanted mutations, likely due to repeated
cutting by Cas9. This direct strategy therefore requires
the screening of several clones by sequencing – a com-
paratively time consuming and costly process. The au-
thors suggest an alternative two-step strategy for the
seamless site-directed mutagenesis of the yeast genome
using CRISPR-Cas9, but did not demonstrate it experi-
mentally. A similar proposition was made shortly after
by Lee et al. [11]. Here, we propose three variations on
this general method, and report its successful application
at 17 positions across the genome of S. cerevisiae hap-
loid strains CENPK113-1A, CEN.PK113-7D and the R57
mutant diploid strain [9].
Using two successive CRISPR events, the method
enables the introduction of point mutations without
altering the PAM or inserting additional silent mutations
(Fig. 1). In the first CRISPR event, the Cas9-induced
DSB is repaired by a homologous repair fragment which
replaces the 20 nucleotide protospacer by a heterologous
sequence of the same length (termed the “stuffer”), pre-
venting repeated cutting by Cas9 (Fig. 1). After curing of
the initial guide, a second gRNA targeting the stuffer is
introduced. The DSB is repaired by a DNA fragment
carrying the desired point mutation, thereby removing
the stuffer and abolishing recognition by the second
gRNA. Stuffer insertion and removal is conveniently
detected by colony PCR. This is in contrast to single-
step methods that make use of sequencing to identify
clones both devoid of unwanted secondary mutations,
and harboring the desired point mutation, unless the
point mutation coincidentally creates or removes a re-
striction site [5]. In the two-step method described here,
the only modification introduced in the parent strain is a
single point mutation (or any desired modification).
In a recent study, a similar approach was used in human
induced pluripotent stem cells for the correction of het-
erozygous β-thalassemia mutations [12]. The piggyBac
transposon system, carrying antibiotic resistance markers
and acting as a stuffer, was inserted into the hemoglobin B
gene by CRISPR assisted HDR. The transposon was then
excised with the help of a specialized transposase, and the
mutation corrected by homologous recombination with
the non-mutant copy of the gene. Use of a two-step pro-
cedure for the seamless alteration of the yeast genome is
also reminiscent of the Delitto perfetto method, whereby
successive rounds of positive and negative selection are
used to transiently introduce a marker cassette [13].
In the present method, a single stuffer with a random
unique sequence is employed in most instances, which
allows for the repeated use of the same targeting gRNA
sequence and PCR primers for confirming the presence
of the stuffer. For inserting or removing single point mu-
tations, protospacer replacement was attempted for 15
out of 17 positions using the sequence 5′-agatgcggga-
gaggttctcg-3′ as a stuffer. Screening by PCR of three
clones per position revealed that the stuffer sequence
was successfully inserted in at least one of the three
clones tested in all but five positions (in genes MAL11,
UBP7 and GDH1 for all strains, and STE5 566 and PBP1
in R57) (Fig. 1). However convenient, we suspected that
the transient disruption of important genes by a stand-
ard stuffer could reduce or abolish cell viability. For ex-
ample, the mutant strain R57 carries mutations in or
near essential genes DOP1 and NOP58 that are known
to be essential in S. cerevisiae [14, 15]. In addition, we
observed that insertion of the stuffer in the ARO1 gene
of S. cerevisiae considerably reduced its growth rate on
YPD medium (data not shown). We therefore hypothe-
sized that failure to insert the stuffer sequence in genes
MAL11, UBP7, GDH1, STE5 (at position 566) and PBP1
could be due to similar viability issues. For the two
essential genes (DOP1, NOP58) and the six previously
unsuccessful positions (ARO1, MAL11, UBP7, GDH1,
STE5 566, PBP1), we designed custom stuffers (and
stuffer targeting gRNAs) that did not disrupt the coding
region using degenerate sequences. Similar to heterology
blocks, our silent stuffers introduced at least seven nu-
cleotide substitutions to protect against repeated cutting
by Cas9.
We were able to insert the silent stuffers at DOP1,
NOP58, ARO1 and STE5 (Fig. 1), and growth defects
were not observed in the resulting strains. However, the
silent stuffer insertion method failed for MAL11, UBP7,
GDH1 and PBP1. Suspecting our choice of gRNA target
sequences to be the cause, we designed, for each of the
four genes, two or three additional gRNAs with targets
evenly spaced along the ORF to increase chances of
DSBs. To avoid having to design stuffer fragments for
each target, we designed donor DNAs containing the
yeGFP sequence with, at their 5′ and 3′ ends, 50-bp
homology to the promoter and terminator of the target
genes. The expected result was the precise replacement
of the native ORFs by yeGFP (Fig. 1). Not presuming of
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the success of any one individual guide, this strategy pre-
vents further recognition by the gRNA/Cas9 complex
anywhere in the gene by replacing the entire target ORF.
The new guides were simultaneously transformed into
yeast with the yeGFP stuffer. Integrants were identified
in all four loci (Fig. 1), suggesting at least one guide per
locus was functional. We suggest that stuffer ORFs can
prove useful when the selection of a functional gRNA
target is problematic. However, we note that it is not
suitable in genes that are essential or strongly affect via-
bility when deleted, in both cases preventing down-
stream transformation and CRISPR events.
In strains containing the short stuffers, the second
CRISPR event used DNA fragments averaging 500 bp
for DSB repair and introduction of point mutations.
Longer fragments spanning the promoter, ORF and ter-
minator were required at loci stuffed with yeGFP. For all
stuffer-containing strains, replacement of the stuffed
sequence by the point mutant sequence was successful
(Fig. 1). Introduction of points mutations was confirmed
by Sanger sequencing revealing no additional unwanted
mutations in the targeted loci (see Fig. 2b for an example).
While the efficiency of stuffer insertion was highly variable
and rarely at 100 %, we observe that for most positions
considered, all clones screened for stuffer removal and
point mutation insertion were positive. CRISPR efficiency
was high at positions bearing the standard short and
yeGFP stuffers, but lower on average for positions carrying
the custom silent stuffers (data not shown). These observa-
tions suggest that a standard stuffer is useful in reducing
the variability of recognition and cutting by the gRNA/
Cas9 complex during the second CRISPR event. Whenever
feasible, we propose that it should be the preferred method
for CRISPR assisted genomic insertion of point mutations.
To demonstrate the usefulness of our seamless stuffer-
assisted site-directed mutagenesis method, we chose to
investigate the effect of a point mutation localized in the
promoter region of gene GSH1, which is responsible for
the committed step in glutathione biosynthesis (Fig. 2a
and [16, 17]). Because the synthesis of reduced glutathi-
one and the recycling of its oxidized form play a major
role in resistance to oxidative stress (Fig. 2a), we hypoth-
esized that a mutation of the GSH1 promoter would
modulate glutathione synthesis in the cell and thereby
affect levels of reactive oxygen species (ROS). Since the
mutant strain R57 was selected for its resistance to
lignocellulosic hydrolysate spent sulfite liquor (SSL), we
used the fluorescent CellROX Deep Red Reagent (Life
Fig. 1 Outline of the two-step, stuffer-assisted genome site-directed mutagenesis strategy. Two variations of the strategy were applied. In the stuffer
strategy a protospacer target sequence located near the site to mutagenize is replaced by a heterologous 20-nucleotide sequence (the stuffer) by
CRISPR-Cas9 assisted homologous recombination, leaving the PAM site intact. The stuffer may be a standard, randomly generated sequence
(the standard stuffer, left box) or a degenerate sequence bearing at least seven mismatches with the original protospacer (a silent stuffer,
middle box). The second CRISPR step uses the stuffer as a protospacer, restoring the original protospacer sequence and introducing the desired
mutation in a single homologous recombination event. A second variation on the strategy replaces the entire target ORF – or nearby ORF if
an intergenic region is the target of mutagenesis – by a heterologous stuffer ORF (e.g. GFP), which is targeted by one or more gRNAs in the
second step (right box). Homologous recombination restores the original ORF with mutations. Successful integration is easily assessed by PCR.
The strategies were tested at the positions indicated in the boxes. Positions are identified by the coordinate of the first nucleotide of the PAM
site (NGG) with respect to the nearest ORF. For each position, stuffer insertion was successful in either all strains tested (green check), two out
of three strains (yellow check), in all strains but led to a slow growth phenotype (yellow-x), or in none of the strains (red-x). Once a stuffer was
inserted, its removal and replacement by the point mutant sequence was successful in all cases
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Fig. 2 Point mutations introduced with the stuffer-assisted genome site-directed mutagenesis method lead to detectable phenotypic changes.
a Simplified representation of glutathione synthesis and recycling. Condensation of glutamate and cysteine by Gsh1p is followed by the addition
of a glycine by Gsh2p, yielding reduced glutathione. Glutathione oxidized by reactive oxygen species (ROS) is recycled to its reduced form by the
NADPH-dependent Glr1p enzyme. b Sequencing shows successful insertion of the stuffer and subsequent introduction of a point mutation in the
GSH1 promoter sequence c ROS accumulation induced by exposure to SSL was compared between a gsh1(A(−73)T) point mutant generated with
the method, and in its parent wildtype strain (WT). ROS accumulation was assessed using flow cytometry, measuring the mean fluorescence of
cells treated with CellROX Deep Red reagent. ROS were measured 16 h after inoculation in minimal medium (Mid-log), after overnight incubation
in undiluted SSL (acute stress), or after 24 and 48 h in minimal medium containing 70 % SSL
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Technologies) and flow cytometry to assess cytosolic
ROS accumulation in wildtype and gsh1 A(−73)T cells
upon exposure to SSL. When grown in non-toxic medium
(YNB 1 % glucose), the wildtype and mutant stains accu-
mulate comparably low levels of ROS (Fig. 2c). Subse-
quent exposure to undiluted SSL similarly increases ROS
levels in both strains. However, following acute stress
induction in 100 % SSL and transfer to YNB 1 % glucose
supplemented with 70 % SSL, the mutant accumulates
markedly lower amounts of ROS after 24 and 48 h incuba-
tion, suggesting the gsh1 A(−73)T mutation affects cell
response to oxidative stress.
In the current study, we report on a strategy to intro-
duce precise changes at the single nucleotide level in the
genome of S. cerevisiae and demonstrate the value of the
method by introducing a point mutation in the promoter
region of GSH1, which leads to a measurable phenotypic
effect. We believe that this two-step procedure can be
applied to any organism with suitable HDR machinery at
virtually any genomic coordinates to modify coding and
non-coding sequences, in essential and non-essential
genes. Furthermore, it is not constrained by the precise
location and sequence of the PAM and protospacer. The
method is less disruptive than similar two-step methods
reported previously [11, 13], because it does not require
the introduction of large transposons or selection cassettes.
Rather, it transiently introduces few potentially silent muta-
tions. However, the implementation of the method we have
presented requires the generation of an intermediate
stuffed mutant, submitted to a second cycle of transform-
ation, PCR verification, sequencing and gRNA curing.
Welcome improvements would allow stuffer integration
and removal from a single transformation using for ex-
ample transient or inducible gRNAs.
Because of its wide applicability, we believe this seam-
less, genome-level site-directed mutagenesis procedure
will prove useful to a wide range of researchers inter-
ested in the precise genome editing of S. cerevisiae and
other organisms.
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